[1] |
CHEN Siying, DING Xueli, LIU Shujia, ZHANG Xiaomeng, ZHANG Bing, LIN Zhijian.
Modeling for Prediction of Cardiotoxicity of Chinese Herbal Medicines
[J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 869-875.
|
[2] |
YANG Yifan, YANG Yanwei, ZHANG Di, XIE Yin, ZHANG Yong, CHEN Xulin, GAO Sutao, GENG Xingchao, QU Zhe.
Quality Control and Test Methods of Human Induced Pluripotent Stem Cells
[J]. Chinese Journal of Pharmacovigilance, 2025, 22(7): 728-734.
|
[3] |
HU Haipeng, YAO Weijie, FENG Xin.
Effects of Yangxue Antai Prescription on Placental Ferroptosis in Recurrent Spontaneous Abortion Mice
[J]. Chinese Journal of Pharmacovigilance, 2025, 22(6): 621-626.
|
[4] |
XIE Ziyue, WANG Chengxiang, HU Yanpeng, LI Lei, CUI Herong.
Clinical Medications and Safety Analysis of Traditional Chinese Medicine for Post-Infection Cough
[J]. Chinese Journal of Pharmacovigilance, 2025, 22(5): 507-512.
|
[5] |
LIU Lianlian, YU Huiyong, WANG Mingzhe, GUO Shanshan, LI Lei, GAO Yue, WEI Shixiang, KE Yinze, WANG Chengxiang.
TCM Medications for Pulmonary Nodules Based on Traditional Chinese Medicine Inheritance Assistance System
[J]. Chinese Journal of Pharmacovigilance, 2025, 22(5): 513-516.
|
[6] |
WANG Fengxin, LI Lei, HUANG Xurui, ZHAO Yun, LING Ruby, YANG Yang, LIANG Changhao, ZENG Yuntao, ZHENG Yingjun, TANG Yuanchen, LIU Jiatao, WANG Chengxiang, WEN Tiancai, LI Ping.
Efficacy and Safety of Danshen Decoction in Treatment of Coronary Heart Disease
[J]. Chinese Journal of Pharmacovigilance, 2025, 22(5): 575-579.
|
[7] |
LI Shuran, XIE Rui, ZHAO Ronghua, BAO Lei, GENG Zihan, SUN Qiyue, CUI Xiaolan, GUO Shanshan, SUN Jing.
Research Progress in the Pathogenesis and Medications of Trigeminal Neuralgia
[J]. Chinese Journal of Pharmacovigilance, 2025, 22(5): 596-600.
|
[8] |
GUO Dongqi, WANG Hao, BAI Xin, BAI Jianqi, SU Hongmei, ZHANG Jingru, GUO Xiaofei, ZHAO Xiaoqi, WANG Min, WANG Yuan, ZHANG Ping.
Identification of Druggable Targets for Intervertebral Disc Degeneration Based on Multi-Omics Data-Driven Mendelian Randomization and Prediction of Traditional Chinese Medicine Interventions
[J]. Chinese Journal of Pharmacovigilance, 2025, 22(3): 241-248.
|
[9] |
BAI Xin, WANG Min, WANG Yuan, BAI Jianqi, SU Shuang, LIU Guanghui, GUO Xiaofei, KANG Jiaqi, GUO Dongqi, ZHANG Yimeng, WANG Hao, ZHAO Xiaoqi, ZHANG Ping.
Traditional Chinese Medicine Used in the Treatment of Gout Complicated with Osteoarthritis
[J]. Chinese Journal of Pharmacovigilance, 2025, 22(3): 258-262.
|
[10] |
JIA Zhichao, HU Siyuan, LI Ruiben, XU Yaqian.
Safety of Children’s Traditional Chinese Medicine Decoction Pieces in Clinical Application and Children’s Drug Development
[J]. Chinese Journal of Pharmacovigilance, 2025, 22(3): 324-328.
|
[11] |
LI Bo, XU Liu, XIE Yuqing, WANG Yiying, DONG Shuai, LIAN Jie, LI Guodong, CAO Huijuan.
Safety and Efficacy of Chinese Herbal Patent Medicines for COVID-19: an Umbrella Review
[J]. Chinese Journal of Pharmacovigilance, 2025, 22(2): 155-161.
|
[12] |
LIANG Xiao, LI Li, XU Xiaolong, BAI Yinglu, YANG Yumei, ZHU Yong, LIU Qingquan.
Advancements in Treatment of Brucellosis with Traditional Chinese Medicine
[J]. Chinese Journal of Pharmacovigilance, 2025, 22(2): 231-234.
|
[13] |
LIU Bo, YUAN Yanan, WANG Yue, CHENG Shuqian, LU Zhiguo, FAN Huihong, SUN Huimin.
Key Technologies for Quality Control of Oligonucleotide Drugs
[J]. Chinese Journal of Pharmacovigilance, 2025, 22(1): 1-9.
|
[14] |
SUN Deyang, SUN Jiabei, LI Wenlong, JIA Juanjuan, ZHANG Wenzai, LIU Yan, HUANG Haiwei, YAO Jing.
Assignment of Chemical Reference Substance of Aminopolyether -a Key Impurity in Fludeoxyglucose [18F] Injection
[J]. Chinese Journal of Pharmacovigilance, 2025, 22(1): 43-46.
|
[15] |
PEI Yusheng, XU Lin, ZHAO Yuxin, CAI Tong, HUA Xiaodong.
Low Endotoxin Recovery and Mitigation Strategies
[J]. Chinese Journal of Pharmacovigilance, 2025, 22(1): 72-75.
|